Drugs / depot octreotide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00781911 Background | Feb 2009 → Jul 2011 | carcinoma, neuroendocrine neoplasm | Eli Lilly and Company | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | depot octreotide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00781911 ↗ |